Covid vaccine stocks: Jabtastic
COVID-19 happened, and then the whole world needed a jab. Meet the vaccine makers who've profited the most.
Photo: National Cancer Institute / Unsplash
Cancer research stocks: Oncology pharmaceutical market
19 symbols
Cancer and cancer care is serious business, but extremely costly. The companies researching and developing preventative care and treatments are often involved in multiple layers of the pharmaceuticals and bio industries, with extremely high investment and revenues from their various ventures.
This Spark contains some of the biggest pharmaceutical and biotech firms involved in cancer research or treatment in the US, all with market capitalizations over $2bn. You can also see mid-cap stocks, and low-cap. But don't rely on this alone. This isn't advice, so make sure you do your own research.
This Spark contains some of the biggest pharmaceutical and biotech firms involved in cancer research or treatment in the US, all with market capitalizations over $2bn. You can also see mid-cap stocks, and low-cap. But don't rely on this alone. This isn't advice, so make sure you do your own research.
Related sparks
Weed stocks: A growing industry
Should you invest in weed stocks? Take a look and see what can help your portfolio grow.
Big pharma stocks: Top pharmaceutical firms
These giants of the drugs world were in focus during the global pandemic, but there's much more to this multi-billion dollar industry than just vaccines.
Mid-weight oncology stocks: The dark horses of cancer research
18 No. of Symbols
Although not mega-sized companies yet, these mid-weight firms play a vital role in cancer treatment.
Low-cap oncology stocks: Small companies fighting cancer
Cancer research has come a long way, and now smaller operations are seeking innovative methods to tackle the disease.
Biotech stocks: A shot in the arm
Though most would happily forget the 2020 pandemic, these biotech stocks have gotten a shot in the arm.